echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > FDA: Heart patients drink grapefruit juice with caution.

    FDA: Heart patients drink grapefruit juice with caution.

    • Last Update: 2020-08-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A recent study published in the American Journal of Clinical Nutrition found that drinking a glass of grapefruit juice a day keeps blood vessels in a healthy state and helps people stay away from heart disease, largely because citrus fruits such as grapefruit are rich in flavonoids that are good for the heart."Daily intake of grapefruit juice helps middle-aged menopausal women stay away from atherosclerosis and maintain the elasticity of blood vessels, allowing blood to flow better into the heart," the
    researchers said in the report. This effect should be associated with flavonoids in grapefruit."
    but researchers caution that drinking grapefruit juice with caution may affect drug effectiveness.
    the U.S. Food and Drug Administration website published an article reminding that grapefruit juice and certain drugs can cause adverse reactions, and may even lead to sudden death. Previous studies have shown that the rich furan toyin in grapefruit inhibits the enzyme activity of the drug that breaks down in the body, leading to a doubling of the amount of medicine that enters the bloodstream."When taking a statin to lower cholesterol and refer to grapefruit juice, there will be more drugs in the blood that can lead to liver damage and even kidney failure, " said Huang Xiumei, director of clinical pharmacology at the U.S. Food and Drug Administration,
    .
    researchers also say that taking the drug is dangerous for several hours before and after drinking grapefruit juice. They caution that common drugs that react with grapefruit juice are mainly six types of statins
    cholesterol-lowering drugs, such as sivastatin, liptatin (attovastatin) and (provastatin);
    Health Times reporter Wu Xiaoyin compiled in the Daily Mail
    all labeled as "Health Times" or "Health Times Network" of the manuscripts are the original content of the Health Times, reproduced please indicate the source of "Health Times Network" and attached to the original link. For content collaboration, please contact 010-65369672
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.